Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice

Ming Che Ho, Chianfang G. Cherng, Yen Ping N Tsai, Chih Yuan Chiang, Jia Ying Chuang, Shu Fang Kao, Lung Yu

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Rationale and objective: Whether monoamine oxidase inhibitors (MAOIs) can be used to suppress the reinforcing effect of cocaine remains unknown. This study was undertaken to examine effects of a long-term dosing regimen with selective MAOIs on cocaine and food reward. Materials and methods: Since single dose of clorgyline (2 mg/kg), deprenyl (1 mg/kg), and pargyline (10 mg/kg) did not acutely affect mouse locomotor activity, these doses were chosen to treat the male C57BL/6j mice on a daily basis. Results: Fourteen consecutive days of pretreatments with clorgyline, deprenyl, or pargyline (one injection per day) did not affect natural reward-supported operant behavior, since acquisition of the lever pressing responses for food pellets under an FR-1 protocol did not differ among these drug- and saline-treated mice. Likewise, 24 consecutive days of pretreatments with clorgyline did not alter acquisition of the cocaine (0.3 mg/kg per infusion)-supported operant responses under an FR-1 protocol. In contrast, 24 days of pretreatments with deprenyl and pargyline abolished the cocaine-supported operant responses under a similar protocol. Twenty-four days of clorgyline treatment enhanced serotonin contents in striatum, nucleus accumbens, and frontal cortex. Frontal cortical 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacidic acid concentrations were decreased following 24 days of pretreatments with deprenyl and pargyline. These changes were not evident in mice pretreated with clorgyline. Conclusions: We suggest that long-term treatments with MAO-B inhibitors may decrease cocaine-supported operant responses in cocaine-naïve mice by selectively decreasing frontal cortical metabolism of dopamine and serotonin.

Original languageEnglish
Pages (from-to)141-149
Number of pages9
JournalPsychopharmacology
Volume205
Issue number1
DOIs
Publication statusPublished - Jul 2009
Externally publishedYes

Fingerprint

Clorgyline
Monoamine Oxidase Inhibitors
Monoamine Oxidase
Reward
Cocaine
Pargyline
Selegiline
Serotonin
Therapeutics
3,4-Dihydroxyphenylacetic Acid
Food
Nucleus Accumbens
Frontal Lobe
Locomotion
Inbred C57BL Mouse
Dopamine
Injections
Acids
Pharmaceutical Preparations

Keywords

  • Cocaine
  • Deprenyl
  • MAO
  • Pargyline
  • Self administration

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ho, M. C., Cherng, C. G., Tsai, Y. P. N., Chiang, C. Y., Chuang, J. Y., Kao, S. F., & Yu, L. (2009). Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice. Psychopharmacology, 205(1), 141-149. https://doi.org/10.1007/s00213-009-1524-5

Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice. / Ho, Ming Che; Cherng, Chianfang G.; Tsai, Yen Ping N; Chiang, Chih Yuan; Chuang, Jia Ying; Kao, Shu Fang; Yu, Lung.

In: Psychopharmacology, Vol. 205, No. 1, 07.2009, p. 141-149.

Research output: Contribution to journalArticle

Ho, Ming Che ; Cherng, Chianfang G. ; Tsai, Yen Ping N ; Chiang, Chih Yuan ; Chuang, Jia Ying ; Kao, Shu Fang ; Yu, Lung. / Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice. In: Psychopharmacology. 2009 ; Vol. 205, No. 1. pp. 141-149.
@article{1dc9c4d7f47e48c888bbc05520b79816,
title = "Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice",
abstract = "Rationale and objective: Whether monoamine oxidase inhibitors (MAOIs) can be used to suppress the reinforcing effect of cocaine remains unknown. This study was undertaken to examine effects of a long-term dosing regimen with selective MAOIs on cocaine and food reward. Materials and methods: Since single dose of clorgyline (2 mg/kg), deprenyl (1 mg/kg), and pargyline (10 mg/kg) did not acutely affect mouse locomotor activity, these doses were chosen to treat the male C57BL/6j mice on a daily basis. Results: Fourteen consecutive days of pretreatments with clorgyline, deprenyl, or pargyline (one injection per day) did not affect natural reward-supported operant behavior, since acquisition of the lever pressing responses for food pellets under an FR-1 protocol did not differ among these drug- and saline-treated mice. Likewise, 24 consecutive days of pretreatments with clorgyline did not alter acquisition of the cocaine (0.3 mg/kg per infusion)-supported operant responses under an FR-1 protocol. In contrast, 24 days of pretreatments with deprenyl and pargyline abolished the cocaine-supported operant responses under a similar protocol. Twenty-four days of clorgyline treatment enhanced serotonin contents in striatum, nucleus accumbens, and frontal cortex. Frontal cortical 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacidic acid concentrations were decreased following 24 days of pretreatments with deprenyl and pargyline. These changes were not evident in mice pretreated with clorgyline. Conclusions: We suggest that long-term treatments with MAO-B inhibitors may decrease cocaine-supported operant responses in cocaine-na{\"i}ve mice by selectively decreasing frontal cortical metabolism of dopamine and serotonin.",
keywords = "Cocaine, Deprenyl, MAO, Pargyline, Self administration",
author = "Ho, {Ming Che} and Cherng, {Chianfang G.} and Tsai, {Yen Ping N} and Chiang, {Chih Yuan} and Chuang, {Jia Ying} and Kao, {Shu Fang} and Lung Yu",
year = "2009",
month = "7",
doi = "10.1007/s00213-009-1524-5",
language = "English",
volume = "205",
pages = "141--149",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice

AU - Ho, Ming Che

AU - Cherng, Chianfang G.

AU - Tsai, Yen Ping N

AU - Chiang, Chih Yuan

AU - Chuang, Jia Ying

AU - Kao, Shu Fang

AU - Yu, Lung

PY - 2009/7

Y1 - 2009/7

N2 - Rationale and objective: Whether monoamine oxidase inhibitors (MAOIs) can be used to suppress the reinforcing effect of cocaine remains unknown. This study was undertaken to examine effects of a long-term dosing regimen with selective MAOIs on cocaine and food reward. Materials and methods: Since single dose of clorgyline (2 mg/kg), deprenyl (1 mg/kg), and pargyline (10 mg/kg) did not acutely affect mouse locomotor activity, these doses were chosen to treat the male C57BL/6j mice on a daily basis. Results: Fourteen consecutive days of pretreatments with clorgyline, deprenyl, or pargyline (one injection per day) did not affect natural reward-supported operant behavior, since acquisition of the lever pressing responses for food pellets under an FR-1 protocol did not differ among these drug- and saline-treated mice. Likewise, 24 consecutive days of pretreatments with clorgyline did not alter acquisition of the cocaine (0.3 mg/kg per infusion)-supported operant responses under an FR-1 protocol. In contrast, 24 days of pretreatments with deprenyl and pargyline abolished the cocaine-supported operant responses under a similar protocol. Twenty-four days of clorgyline treatment enhanced serotonin contents in striatum, nucleus accumbens, and frontal cortex. Frontal cortical 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacidic acid concentrations were decreased following 24 days of pretreatments with deprenyl and pargyline. These changes were not evident in mice pretreated with clorgyline. Conclusions: We suggest that long-term treatments with MAO-B inhibitors may decrease cocaine-supported operant responses in cocaine-naïve mice by selectively decreasing frontal cortical metabolism of dopamine and serotonin.

AB - Rationale and objective: Whether monoamine oxidase inhibitors (MAOIs) can be used to suppress the reinforcing effect of cocaine remains unknown. This study was undertaken to examine effects of a long-term dosing regimen with selective MAOIs on cocaine and food reward. Materials and methods: Since single dose of clorgyline (2 mg/kg), deprenyl (1 mg/kg), and pargyline (10 mg/kg) did not acutely affect mouse locomotor activity, these doses were chosen to treat the male C57BL/6j mice on a daily basis. Results: Fourteen consecutive days of pretreatments with clorgyline, deprenyl, or pargyline (one injection per day) did not affect natural reward-supported operant behavior, since acquisition of the lever pressing responses for food pellets under an FR-1 protocol did not differ among these drug- and saline-treated mice. Likewise, 24 consecutive days of pretreatments with clorgyline did not alter acquisition of the cocaine (0.3 mg/kg per infusion)-supported operant responses under an FR-1 protocol. In contrast, 24 days of pretreatments with deprenyl and pargyline abolished the cocaine-supported operant responses under a similar protocol. Twenty-four days of clorgyline treatment enhanced serotonin contents in striatum, nucleus accumbens, and frontal cortex. Frontal cortical 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacidic acid concentrations were decreased following 24 days of pretreatments with deprenyl and pargyline. These changes were not evident in mice pretreated with clorgyline. Conclusions: We suggest that long-term treatments with MAO-B inhibitors may decrease cocaine-supported operant responses in cocaine-naïve mice by selectively decreasing frontal cortical metabolism of dopamine and serotonin.

KW - Cocaine

KW - Deprenyl

KW - MAO

KW - Pargyline

KW - Self administration

UR - http://www.scopus.com/inward/record.url?scp=67649440684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649440684&partnerID=8YFLogxK

U2 - 10.1007/s00213-009-1524-5

DO - 10.1007/s00213-009-1524-5

M3 - Article

C2 - 19343328

AN - SCOPUS:67649440684

VL - 205

SP - 141

EP - 149

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -